SORBENT REMOVAL OF ANTI-CANCER DRUGS

被引:0
|
作者
RAHMAN, A
WINCHESTER, JF
KESSLER, A
SLAVIK, M
SCHEIN, P
机构
[1] GEORGE WASHINGTON UNIV,SCH MED,VINCENT T LOMBARDI CANC RES CTR,DIV MED ONCOL,WASHINGTON,DC 20007
[2] GEORGE WASHINGTON UNIV,SCH MED,DIV NEPHROL,WASHINGTON,DC 20007
来源
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1978年 / 19卷 / MAR期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:233 / 233
页数:1
相关论文
共 50 条
  • [41] Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes
    Moku, Gopikrishna
    Gulla, Suresh Kumar
    Nimmu, Narendra Varma
    Khalid, Sara
    Chaudhuri, Arabinda
    BIOMATERIALS SCIENCE, 2016, 4 (04) : 627 - 638
  • [42] ANTI-BACTERIAL ACTIVITY OF ANTI-CANCER DRUGS
    GEMMELL, CG
    HARDING, NGL
    JOURNAL OF MEDICAL MICROBIOLOGY, 1981, 14 (02) : R7 - R8
  • [43] Targeting Cancer Metabolism and Current Anti-Cancer Drugs
    Sukjoi, Witchuda
    Ngamkham, Jarunya
    Attwood, Paul V.
    Jitrapakdee, Sarawut
    REVIEWS ON NEW DRUG TARGETS IN AGE-RELATED DISORDERS, PT II, 2021, 1286 : 15 - 48
  • [44] Cancer Cell Models for the Development of Anti-Cancer Drugs
    Telang, Nitin T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [45] MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
    Pennati, Marzia
    Folini, Marco
    Gandellini, Paolo
    Zaffaroni, Nadia
    CURRENT DRUG TARGETS, 2016, 17 (03) : 257 - 265
  • [46] Prescribing anti-cancer drugs in elderly cancer patients
    Monfardini, S
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (18) : 2341 - 2346
  • [47] Xanthone derivatives as potential anti-cancer drugs
    Lin, CN
    Liou, SJ
    Lee, TH
    Chuang, YC
    Won, SJ
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (05) : 539 - 544
  • [48] Novel anti-cancer drugs and therapeutic approaches
    Bergmann-Leitner, E
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) : 259 - 260
  • [49] Benefit and Harms of New Anti-Cancer Drugs
    Francisco E. Vera-Badillo
    Mustafa Al-Mubarak
    Arnoud J. Templeton
    Eitan Amir
    Current Oncology Reports, 2013, 15 : 270 - 275
  • [50] Guidelines for clinical evaluation of anti-cancer drugs
    Minami, Hironobu
    Kiyota, Naomi
    Kimbara, Shiro
    Ando, Yuichi
    Shimokata, Tomoya
    Ohtsu, Atsushi
    Fuse, Nozomu
    Kuboki, Yasutoshi
    Shimizu, Toshio
    Yamamoto, Noboru
    Nishio, Kazuto
    Kawakami, Yutaka
    Nihira, Shin-ichi
    Sase, Kazuhiro
    Nonaka, Takahiro
    Takahashi, Hideaki
    Komori, Yukiko
    Kiyohara, Koshin
    CANCER SCIENCE, 2021, 112 (07) : 2563 - 2577